112 related articles for article (PubMed ID: 30809635)
1. RAB14 activates MAPK signaling to promote bladder tumorigenesis.
Chao H; Deng L; Xu F; Fu B; Zhu Z; Dong Z; Liu YN; Zeng T
Carcinogenesis; 2019 Nov; 40(11):1341-1351. PubMed ID: 30809635
[TBL] [Abstract][Full Text] [Related]
2. Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B.
Zhang Q; Wang L; Yu L; Yu Q; Xue L; Shen Z
Mol Carcinog; 2024 Jun; 63(6):1106-1116. PubMed ID: 38441297
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
4. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
6. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
[TBL] [Abstract][Full Text] [Related]
7. LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
Wang W; Yang C; Nie H; Qiu X; Zhang L; Xiao Y; Zhou W; Zeng Q; Zhang X; Wu Y; Liu J; Ying M
Int J Cancer; 2019 Mar; 144(6):1345-1355. PubMed ID: 30006972
[TBL] [Abstract][Full Text] [Related]
8. The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor.
Wang B; Fan X; Wang L; Wei X
Mol Carcinog; 2024 Jun; 63(6):1174-1187. PubMed ID: 38501385
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
[TBL] [Abstract][Full Text] [Related]
10. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
11. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
12. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
13. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
[TBL] [Abstract][Full Text] [Related]
14. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of miR‑490‑3p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
Wang B; Yin M; Cheng C; Jiang H; Jiang K; Shen Z; Ye Y; Wang S
Int J Oncol; 2018 Sep; 53(3):1247-1256. PubMed ID: 29916545
[TBL] [Abstract][Full Text] [Related]
16. HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.
Lv D; Wu H; Xing R; Shu F; Lei B; Lei C; Zhou X; Wan B; Yang Y; Zhong L; Mao X; Zou Y
Oncotarget; 2017 Feb; 8(8):13586-13599. PubMed ID: 28088793
[TBL] [Abstract][Full Text] [Related]
17. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
18. Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Yang J; Wang B; Chen H; Chen X; Li J; Chen Y; Yuan D; Zheng S
Cell Prolif; 2019 Mar; 52(2):e12560. PubMed ID: 30515906
[TBL] [Abstract][Full Text] [Related]
19. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
20. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
Jiang T; Lu X; Yang F; Wang M; Yang H; Xing N
FEBS Open Bio; 2020 Oct; 10(10):2107-2121. PubMed ID: 32865871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]